Evaluation of bloodstream infections during chemotherapy-induced febrile neutropenia in patients with malignant hematological diseases single center experience /
From year to year, it is important to get an overview of the occurrence of causative agents in febrile neutropenic patients to determine the empiric treatment. Thus our aims were to evaluate a four-year period regarding the prevalence of bloodstream infections and the most important causative agents...
Elmentve itt :
Szerzők: |
Piukovics Klára Terhes Gabriella Lázár Andrea Tímár Flóra Borbényi Zita Zsoldiné Urbán Edit |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
Akadémiai Kiadó
2015
|
Sorozat: | EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY
5 No. 3 |
doi: | 10.1556/1886.2015.00021 |
mtmt: | 2961054 |
Online Access: | http://publicatio.bibl.u-szeged.hu/12080 |
Hasonló tételek
-
COVID-19 infection in adult patients with hematological malignancies a European Hematology Association Survey (EPICOVIDEHA) /
Szerző: Pagano Livio, et al.
Megjelent: (2021) -
RGB-02 (biosimilar pegfilgrastim) in the treatment of chemotherapy-induced neutropenia
Szerző: Sántha Dóra, et al.
Megjelent: (2019) -
New molecular approach in the diagnosis of bloodstream infections
Szerző: Horváth Ádám -
Four cases of bacteraemia caused by Fusobacterium nucleatum in febrile, neutropenic patients
Szerző: Terhes Gabriella, et al.
Megjelent: (2011) -
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies results from EPICOVIDEHA survey /
Szerző: Pagano Livio, et al.
Megjelent: (2022)